Shuai Li

机构：CHI Health Creighton University Medical Center - Bergan Mercy · ORCID：0000-0002-8946-5802

发表论文 71 篇 · 总被引 1266 次 · h-index 18

代表论文

• Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways (2023 · Discover Oncology · 被引 15)
• Association between metabolic syndrome and early-stage colorectal cancer (2023 · BMC Cancer · 被引 14)
• Uncovering the Mechanism of Scopoletin in Ameliorating Psoriasis-Like Skin Symptoms via Inhibition of PI3K/Akt/mTOR Signaling Pathway (2024 · Inflammation · 被引 7)
• Oscillatory shear stress activates integrin β3, blocking autophagic flux in endothelial cells and promoting endothelial cells senescence (2025 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 被引 5)
• Cytochrome P450-Catalyzed Tetrahydrofuran Formation via Dual Pathways in Avermectin Biosynthesis (2025 · ACS Catalysis · 被引 5)
• A novel angiotensin-converting enzyme (ACE) inhibitory peptide from Alaska pollock (Gadus chalcogrammus) Skin: Preparation, screening, in vitro activity evaluation, and network pharmacology analysis (2025 · Food Bioscience · 被引 4)